Reassessing US Obesity Prevalence Under the 2025 Lancet Commission's Anthropometric Criteria
Mayo Clinic Proceedings · 2026-09
DOI: 10.1016/j.mayocp.2026.08.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mayo Clinic Proceedings, 2026-09. Verfasst von Ibrahim Hassan und 3 weiteren Autor:innen. Beteiligte Einrichtung: DeBakey Heart and Vascular Center, Houston Methodist Academic Institute, Houston, TX. Electronic address: IbrHassanMD@gmail.com. Die Arbeit nennt 5 Literaturangaben. Gefördert von: American Heart Association.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- DeBakey Heart and Vascular Center, Houston Methodist Academic Institute, Houston, TX. Electronic address: IbrHassanMD@gmail.com.
- The Davis Women's Heart Center, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX; The Baim Institute for Clinical Research, Boston, MA.
- John Ochsner Heart and Vascular Institute, Ochsner Clinical School, University of Queensland School of Medicine, New Orleans, LA.
- Cardiology Department and Cardiovascular Imaging Research Center, Massachusetts General Hospital and Harvard Medical School, Boston; Division of Outcomes Research, Massachusetts General Hospital and Harvard Medical Scho…
Förderung
- American Heart Association
Zitieren
APA
Hassan, I., Gulati, M., Lavie, C. J., & Abohashem, S. (2026). Reassessing US Obesity Prevalence Under the 2025 Lancet Commission's Anthropometric Criteria. Mayo Clinic Proceedings. https://doi.org/10.1016/j.mayocp.2026.08.025
Vancouver
Hassan I, Gulati M, Lavie CJ, Abohashem S. Reassessing US Obesity Prevalence Under the 2025 Lancet Commission's Anthropometric Criteria. Mayo Clinic Proceedings. 2026. doi:10.1016/j.mayocp.2026.08.025
BibTeX
@article{Hassan2026,
author = {Hassan, Ibrahim and Gulati, Martha and Lavie, Carl J and Abohashem, Shady},
title = {Reassessing US Obesity Prevalence Under the 2025 Lancet Commission's Anthropometric Criteria},
journal = {Mayo Clinic Proceedings},
year = {2026},
doi = {10.1016/j.mayocp.2026.08.025}
}
EUVIMED